GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kangmei Pharmaceutical Co Ltd (SHSE:600518) » Definitions » 5-Year EBITDA Growth Rate

Kangmei Pharmaceutical Co (SHSE:600518) 5-Year EBITDA Growth Rate : 0.00% (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Kangmei Pharmaceutical Co 5-Year EBITDA Growth Rate?

Kangmei Pharmaceutical Co's EBITDA per Share for the three months ended in Sep. 2024 was ¥0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Kangmei Pharmaceutical Co was 95.00% per year. The lowest was -50.90% per year. And the median was 24.70% per year.


Competitive Comparison of Kangmei Pharmaceutical Co's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Kangmei Pharmaceutical Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kangmei Pharmaceutical Co's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kangmei Pharmaceutical Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Kangmei Pharmaceutical Co's 5-Year EBITDA Growth Rate falls into.



Kangmei Pharmaceutical Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Kangmei Pharmaceutical Co  (SHSE:600518) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Kangmei Pharmaceutical Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Kangmei Pharmaceutical Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Kangmei Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Taike Road, Xiameilin, Futian District, Guangdong, Shenzhen, CHN, 518000
Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the trading of Chinese herbal medicines, production and sales of Chinese herbal medicine slices, Chinese patent medicine preparations, health foods, chemical drugs and medical devices, modern pharmaceutical logistics system.
Executives
Xu Dong Jin Director
Li Jian Hua senior management
Qiu Xi Wei Director
Wang Min senior management
Peng Qin senior management
Ma Xing Tian Director
Lin Guo Xiong senior management
Zhuang Yi Qing senior management
Wen Shao Sheng Supervisors

Kangmei Pharmaceutical Co Headlines

No Headlines